Therapeutic and Diagnostic Implications of T Cell Scarring in Celiac Disease and Beyond.
Autoimmunity
HLA
T cells
celiac disease
diagnosis
therapy
Journal
Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
29
03
2019
revised:
22
05
2019
accepted:
28
05
2019
pubmed:
25
7
2019
medline:
27
6
2020
entrez:
24
7
2019
Statut:
ppublish
Résumé
Few therapeutic and diagnostic tools specifically aim at T cells in autoimmune disorders, but are T cells a narrow target in these diseases? Lessons may be learned from celiac disease (CeD), one of the few autoimmune disorders where the T cell driving antigens are known, i.e. dietary gluten proteins. T cell clonotypes specific to gluten are expanded, persist for decades and express a distinct phenotype in CeD patients. Cells with this phenotype are increased also in other autoimmune conditions. Accordingly, disease-specific CD4
Identifiants
pubmed: 31331739
pii: S1471-4914(19)30126-1
doi: 10.1016/j.molmed.2019.05.009
pii:
doi:
Substances chimiques
Glutens
8002-80-0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
836-852Informations de copyright
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.